Inhibition of prostate cancer-meditated osteoblastic bone lesions by the low-calcemic analog 1alpha-hydroxymethyl-16-ene-26,27-bishomo-25-hydroxy vitamin D3. (Q40388748)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inhibition of prostate cancer-meditated osteoblastic bone lesions by the low-calcemic analog 1alpha-hydroxymethyl-16-ene-26,27-bishomo-25-hydroxy vitamin D3. |
scientific article |
Statements
1 reference
Inhibition of prostate cancer-meditated osteoblastic bone lesions by the low-calcemic analog 1alpha-hydroxymethyl-16-ene-26,27-bishomo-25-hydroxy vitamin D3. (English)
1 reference
Sara Peleg
1 reference
Farhana Khan
1 reference
Nora M Navone
1 reference
Dianna D Cody
1 reference
Evan M Johnson
1 reference
Carolyn S Van Pelt
1 reference
Gary H Posner
1 reference
2 August 2005
1 reference
1 reference
Identifiers
1 reference